Hayate Technology

Hayate Technology is a chemical intermediate manufacturing subsidiary of Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin), a leading biopharmaceutical company based in Chengdu, China. The company serves as a critical component of Biokin's vertically integrated business model, providing the specialized chemical building blocks and intermediates required for the synthesis of active pharmaceutical ingredients (APIs). Hayate Technology's operations are primarily focused on supporting Biokin's innovative oncology pipeline, which includes advanced therapeutic modalities such as bispecific antibodies and antibody-drug conjugates (ADCs). By maintaining in-house production of these essential chemical components, Hayate Technology ensures supply chain resilience, rigorous quality control, and cost-efficiency for Biokin's clinical and commercial-stage programs, including the lead asset Iza-bren (BL-B01D1).